Validity of donor-reported iron supplementation practices obtained at the time of donation
- PMID: 36606513
- DOI: 10.1111/trf.17235
Validity of donor-reported iron supplementation practices obtained at the time of donation
Abstract
Background: Iron supplementation (IS) improves blood donors' iron stores and allows more frequent blood donation. Understanding the accuracy of self-reported IS is helpful for potential application of IS practices to donor eligibility or donation intervals.
Methods: Successful whole blood and red cell apheresis donors completed a survey at donation on the use of select dietary supplements. Respondents reporting use of either iron pills (IP) or multivitamins (MV) were invited by email to complete a similar follow-up survey 6-8 weeks later and to provide the quantitative iron content of IS by referring the donor to the pill bottle label. Consistency between baseline and follow-up responses was assessed overall and by pill type and demographic variables.
Results: Of 2444 donors answering the baseline survey, 40% (978) reported MV or IP at donation, 354 of whom completed the follow-up survey. A majority of survey respondents (56%-61%) reported taking iron across the two surveys, and 21%-24% took MV but were uncertain if their pills contained iron. Of 215 reporting IS at baseline, overall concordance at follow-up was 68% and was higher for donors who were female, ≥50-years old, and taking iron as an iron pill rather than in a multivitamin.
Conclusion: Consistency of donor responses may be insufficient for use in guiding donor eligibility. Referring donors to their pill bottles was unsuccessful in improving the high frequency of uncertain responses. Incorporating IS into donor eligibility determinations is a complex endeavor that will benefit from careful planning and from post-implementation monitoring.
Keywords: blood donation; deferral; hemoglobin; iron deficiency; iron supplementation.
© 2023 AABB.
References
REFERENCES
-
- Spencer BR, Guo Y, Cable RG, Kiss JE, Busch MP, Page GP, et al. Iron status and risk factors for iron depletion in a racially/ethnically diverse blood donor population. Transfusion. 2019;59(10):3146-56. https://doi.org/10.1111/trf.15448 [published Online First: 2019/07/19].
-
- Spencer BR, Bialkowski W, Creel DV, Cable RG, Kiss JE, Stone M, et al. Elevated risk for iron depletion in high-school age blood donors. Transfusion. 2019;59(5):1706-16. https://doi.org/10.1111/trf.15133 [published Online First: 2019/01/12].
-
- Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, et al. Iron deficiency in blood donors: the REDS-II donor iron status evaluation (RISE) study. Transfusion. 2012;52(4):702-11. https://doi.org/10.1111/j.1537-2995.2011.03401.x [published Online First: 2011/10/26].
-
- Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, et al. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II donor iron status evaluation (RISE) study. Transfusion. 2011;51(3):511-22. https://doi.org/10.1111/j.1537-2995.2010.02865.x [published Online First: 2010/09/02].
-
- United States Food and Drug Administration. Requirements for blood and blood components intended for transfusion or for further manufacturing use. In: Services HaH, ed. Washington D.C.: Federal Register, 2015:29841-906.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
